Niagen Bioscience, Inc. Common Stock
Market Cap
260M
Short interest (Jul 15)
6.0%
Net Short (Jul 27 ): 0.0%
Borrow Fee
0.41%
↑ 2.2%
Available Shares
7M
↑ 2.3%
Price Chart
Company Overview
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.